Importantly, peptide-antibody interactions were shared by rAbs and native IgG from the same patient. Three peptides strongly interacted with at least one other MS CSF, but not to inflammatory CNS controls. 
Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Important features of disease are the persistence of increased numbers of B-lymphocytes and plasma cells, along with bands of oligoclonal IgG in the brain and cerebrospinal fluid (CSF). In chronic infectious diseases of the CNS, OCBs are antibody directed against the causative agent (reviewed in Gilden, 2005) . Recent studies have demonstrated that recombinant antibodies (rAb) generated from clonally expanded plasma cells in the CSF of patients with subacute sclerosing panencephalitis or optic neuritis are directed against the disease relevant antigens (Burgoon et al., 2005; Owens et al., 2006; Yu et al., 2009; Bennett et al., 2009 ). The presence of B cell follicle-like structures in the meninges of MS patients (Aloisi and Pujol-Borrell, 2006; Magliozzi et al., 2007) , and the efficacy of B cell depletion therapy with Rituximab, an antibody directed against the B cell surface marker CD20 (Hauser et al., 2008) provide evidence for a role of B cells in the pathogenesis of MS.
By fluorescence activated cell sorting (FACS) and IgG variable region sequence analysis, our lab and others demonstrated the presence of a restricted clonal IgG population and extensive somatic mutations in MS CSF CD138 + plasma cells (Owens et al., 1998 (Owens et al., , 2003 Ritchie et al., 2004; Monson et al., 2005) , features of an antigen-driven response. Furthermore, Several studies have identified possible targets of the antibody response in MS by panning phage displayed random peptide libraries with CSF IgG, and found that peptide antigens in MS are specific to individual antibody response (Cortese et al., 1996 (Cortese et al., , 1998 (Cortese et al., , 2001 Archelos et al., 1998) . We have generated rAbs from clonally expanded plasma cells in the CSF of patients with MS. Herein, we report for the first time a comparative study of peptide antigenic specificity between native IgG and rAbs generated from clonally expanded plasma cells in MS CSF.
Materials methods

Generation of recombinant antibody
CD138
+ plasma cell sorting and IgG heavy and light chain variable sequence amplification were performed as described (Ritchie et al., 2004) . The construction and generation of all recombinant antibodies (rAbs) in this study were as reported (Owens et al., 2009) . Journal of Neuroimmunology 233 (2011) 192-203 
